Clinical Trial: Evaluation of Safety and Immunogenicity of rVSV?G-SEBOV-GP Vaccine in Adults With Good General Health
Study Status: ACTIVE_NOT_RECRUITING
Recruit Status: ACTIVE_NOT_RECRUITING
Condition: Ebola Sudan Virus Disease
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Single-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV?G-SEBOV-GP Vaccine at 3 Dose Levels in Adults in Good General Health
Brief Summary:
A Phase 1, Single-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV?G-SEBOV-GP Vaccine at 3 Dose Levels in Adults in Good General Health
Read more